血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法)
Multiplex Assay Kit for Thrombomodulin (TM) ,etc. by FLIA (Flow Luminescence Immunoassay)
CD141; THBD; BDCA3; THRM; Fetomodulin
(注:單次混測多因子不超過8個指標(biāo) )
- 編號LMA529Hu
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 實驗方法雙抗夾心
- 反應(yīng)時長3.5h
- 檢測范圍2.93-3000pg/mL
- 靈敏度最小可檢測劑量小于等于0.977 pg/mL.
- 樣本類型Plasma
- 下載 英文說明書 中文說明書
- 規(guī)格 8指標(biāo)數(shù) 7指標(biāo)數(shù) 6指標(biāo)數(shù) 5指標(biāo)數(shù) 4指標(biāo)數(shù) 3指標(biāo)數(shù) 2指標(biāo)數(shù)1指標(biāo)數(shù)
- 價格 ¥ 2359 ¥ 2449 ¥ 2586 ¥ 2767 ¥ 2948 ¥ 3221 ¥ 3629 計算器 ¥ 4536 添加到價格計算器
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法)(加標(biāo)樣品),重復(fù)測定并計算其均值,回收率為測定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 80-99 | 80 |
EDTA plasma(n=5) | 86-102 | 91 |
heparin plasma(n=5) | 92-101 | 96 |
sodium citrate plasma(n=5) | 91-99 | 96 |
精密度
精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定,每個樣本使用同一試劑盒重復(fù)測定8次,分別計算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法)含量的測定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 91-101% | 85-103% | 81-91% | 78-104% |
EDTA plasma(n=5) | 80-90% | 95-105% | 84-101% | 89-103% |
heparin plasma(n=5) | 89-96% | 78-101% | 83-93% | 93-105% |
sodium citrate plasma(n=5) | 78-99% | 91-101% | 83-92% | 91-99% |
穩(wěn)定性
經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內(nèi)溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。
實驗流程
1. 實驗前標(biāo)準品、試劑及樣本準備;
2. 加樣(標(biāo)準品、樣本、磁珠)標(biāo)準品或樣本100μL及磁珠10μL,
37°C酶標(biāo)板振蕩器孵育90分鐘;
3. 磁吸甩干,加檢測溶液A100μL,37°C酶標(biāo)板振蕩器孵育60分鐘;
4. 磁吸洗板3次;
5. 加檢測溶液B100μL,37°C振動孵育30分鐘;
6. 磁吸洗板3次;
7. 加鞘液100μL,旋渦震蕩2分鐘后讀數(shù)。
實驗原理
將血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法)抗體包被于磁珠,制成固相載體,向微孔中分別加入標(biāo)準品或標(biāo)本以及磁珠,其中的血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法)抗體,將未結(jié)合的生物素化抗體洗凈后,加入PE標(biāo)記的親和素,再次徹底洗滌后即可上機讀數(shù)。MFI值和樣品中的血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法)呈正相關(guān)。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA529Hu61 | 血栓調(diào)節(jié)蛋白(TM)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA529Hu03 | 血栓調(diào)節(jié)蛋白(TM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA529Hu02 | 血栓調(diào)節(jié)蛋白(TM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA529Hu62 | 血栓調(diào)節(jié)蛋白(TM)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA529Hu01 | 血栓調(diào)節(jié)蛋白(TM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA529Hu01 | 血栓調(diào)節(jié)蛋白(TM)多克隆抗體 | WB; IHC; ICC; IP. |
PAA529Hu02 | 血栓調(diào)節(jié)蛋白(TM)多克隆抗體 | WB; IHC; ICC; IP. |
PAA529Hu03 | 血栓調(diào)節(jié)蛋白(TM)多克隆抗體 | WB; IHC; ICC; IP. |
LAA529Hu71 | 血栓調(diào)節(jié)蛋白(TM)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA529Hu22 | 血栓調(diào)節(jié)蛋白(TM)單克隆抗體 | WB; IHC; ICC; IP. |
MAA529Hu25 | 血栓調(diào)節(jié)蛋白(TM)單克隆抗體 | WB; IHC; ICC; IP. |
MAA529Hu27 | 血栓調(diào)節(jié)蛋白(TM)單克隆抗體 | WB; IHC; ICC; IP. |
MAA529Hu28 | 血栓調(diào)節(jié)蛋白(TM)單克隆抗體 | WB |
MAA529Hu29 | 血栓調(diào)節(jié)蛋白(TM)單克隆抗體 | WB |
MAA529Hu21 | 血栓調(diào)節(jié)蛋白(TM)單克隆抗體 | WB; IHC; ICC; IP. |
RAA529Hu21 | 血栓調(diào)節(jié)蛋白(TM)重組抗體 | WB; IFC; IHC; IP. |
MAA529Hu23 | 血栓調(diào)節(jié)蛋白(TM)單克隆抗體 | WB; IHC; ICC; IP. |
MAA529Hu24 | 血栓調(diào)節(jié)蛋白(TM)單克隆抗體 | WB; IHC; ICC; IP. |
FAA529Hu52 | 抗血栓調(diào)節(jié)蛋白(TM)單克隆抗體(別藻藍蛋白標(biāo)記) | FCM |
SEA529Hu | 血栓調(diào)節(jié)蛋白(TM)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA529Hu | 血栓調(diào)節(jié)蛋白(TM)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
PLoS One | A Non-Lethal Traumatic/Hemorrhagic Insult Strongly Modulates the Compartment-Specific PAI-1 Response in the Subsequent Polymicrobial Sepsis [PubMed: PMC3568129] |
Clin Appl Thromb Hemost. | Is There Any Association Between Thrombosis and Tissue Factor Pathway Inhibitor Levels in Patients With Vitamin D Deficiency? [Pubmed: 24203351] |
медицинские науки | КЛЕТОЧНО-МОЛЕКУЛЯРНЫЕ МАРКЕРЫ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ И СИСТЕМНОГО ГЕМОСТАЗА ПРИ ВИБРАЦИОННОЙ БОЛЕЗНИ В … [Ru:Source] |
FASEB J. | Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice [Pubmed:24451386] |
Gynecol Endocrinol. | The effect of hormone therapy on biochemical and ultrasound parameters associated with atherosclerosis in 46, XY DSD individuals with female phenotype [Pubmed:24911331] |
Informa Healthcare | Changes in cardiac thrombomodulin and heat shock transcription factor 1 expression and peripheral thrombomodulin and catecholamines during hypothermia in rats [Pubmed:25109347] |
Bone Marrow Transplant. | Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen [Pubmed:25243628] |
Biomed Res Int | Basic Fibroblast Growth Factor Ameliorates Endothelial Dysfunction in Radiation-Induced Bladder Injury [PubMed: 26351640] |
Molecular Nutrition & Food Research | Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptors [PubMed: 25546502] |
Acta Biomater | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study [PubMed: 26689470] |
MEDICINE AND EDUCATION IN SIBERIA | КЛЕТОЧНО-МОЛЕКУЛЯРНЫЕ МАРКЕРЫ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ И СИСТЕМНОГО ГЕМОСТАЗА ПРИ ВИБРАЦИОННОЙ БОЛЕЗНИ В СОЧЕТАНИИ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ [Cozo: Mos] |
Acta Biomaterialia | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study [Pubmed:26689470] |
Bone Marrow Transplantation | The?fifth?epidermal?growth?factor-like?region?of?thrombomodulin?exerts?cytoprotective?functionand?prevents?SOS?in a?murine?model. [pubmed:27427915] |
BMC Vet Res. | Blood markers of fibrinolysis and endothelial activation in canine babesiosis. [pubmed:28363279] |
Haematologica | Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain [Pubmed:29903766] |
Biomedicine & Pharmacotherapy | Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells [Pubmed:29775893] |
Scientific Reports | Association between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea [Pubmed: 31882827] |
Intensive Care Medicine Experimental | Preservation of renal endothelial integrity and reduction of renal edema by aprotinin does not preserve renal perfusion and function following experimental?… [34169407] |